1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hua, Q.X. Nakagawa, S. Hu, S.Q. Jia, W. Weiss, M.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C3 H7 N O3 105.093 D-SERINE D-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 281 24900 24909 10.1074/jbc.M602691200 16762918 Toward the Active Conformation of Insulin: Stereospecific modulation of a structural switch in the B chain. 2006 10.2210/pdb2hh4/pdb pdb_00002hh4 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2383.698 insulin A chain 1 man polymer 3440.920 insulin B chain G8(DSN), H10D, P28K, K29P 1 man polymer no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no yes FVNQHLC(DSN)SDLVEALYLVCGERGFFYTKPT FVNQHLCSSDLVEALYLVCGERGFFYTKPT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample INS 9606 Homo sapiens 562 Escherichia coli human Homo Escherichia sample INS 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2006-07-18 1 1 2008-05-01 1 2 2011-07-13 1 3 2021-10-20 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details RCSB Y RCSB 2006-06-27 REL REL THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES. structures with the lowest energy 40 20 2D TOCSY NOESY COSY 7.0 298 K RMSD VALUES FOR ALL 20 STRUCTURES VERSUS GEOMETRIC AVERAGE: (BACKBONE, A2-A20, B4-B24) 0.51 ANGSTROM DISTANCE GEOMETRY AND SIMULATED ANNEALING 1 BRUNGER (X-PLOR), BRUNGER (CNS) refinement X-PLOR 3.85, CNS 1.1 structure solution XwinNMR 3.5 700 Bruker DRX GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B DSN 8 n 8 DSN 8 B SER 9 n 9 SER 9 B ASP 10 n 10 ASP 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B LYS 28 n 28 LYS 28 B PRO 29 n 29 PRO 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric B DSN 8 D-SERINE B DSN 8 SER 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B O H ALA VAL 14 18 1.52 2 B B OG1 H THR LYS 27 28 1.57 2 B B O H VAL TYR 12 16 1.58 3 B B O H VAL TYR 12 16 1.51 4 B B O H GLU LEU 13 17 1.41 4 B B O H ALA VAL 14 18 1.53 5 B B HB2 OH DSN TYR 8 26 1.08 5 B B O H ALA VAL 14 18 1.37 5 B B OG HH DSN TYR 8 26 1.38 5 B B O H LEU LEU 11 15 1.50 5 B B CB OH DSN TYR 8 26 1.94 6 B B HB3 HH DSN TYR 8 26 1.29 6 B B O H ALA VAL 14 18 1.37 6 B B O H GLU LEU 13 17 1.54 6 B B O H LEU LEU 11 15 1.55 7 B B O H ALA VAL 14 18 1.34 8 B B O H ALA VAL 14 18 1.49 9 B B HB2 HH DSN TYR 8 26 1.06 9 A B HA HB2 CYS CYS 7 7 1.30 9 B B O H ALA VAL 14 18 1.32 9 B B O H GLU LEU 13 17 1.57 10 B B O H ALA VAL 14 18 1.37 10 A A O HG1 GLU THR 4 8 1.59 10 A A O OG1 GLU THR 4 8 1.86 11 B B O H ALA VAL 14 18 1.57 12 B B O H ALA VAL 14 18 1.40 14 B B HB2 HH DSN TYR 8 26 1.30 14 B B HB3 HH DSN TYR 8 26 1.34 14 B B O H ALA VAL 14 18 1.35 14 B B HB3 OH DSN TYR 8 26 1.55 16 B B O H ALA VAL 14 18 1.47 17 B B OG1 H THR LYS 27 28 1.46 17 B B O H VAL TYR 12 16 1.59 18 B B O H VAL TYR 12 16 1.56 19 B B O H VAL TYR 12 16 1.59 1 A GLU 4 -70.30 -104.43 1 A GLN 5 -39.85 -30.70 1 A CYS 6 -59.71 -74.92 1 A SER 9 -141.67 -133.35 1 B VAL 2 -156.82 -41.10 1 B GLN 4 -127.51 -159.74 1 B SER 9 -49.61 -4.50 1 B PHE 25 -160.99 119.17 1 B TYR 26 -77.33 -130.68 1 B THR 27 -79.88 -91.43 1 B LYS 28 30.57 64.60 1 B PRO 29 -66.57 91.85 2 A CYS 6 -90.50 -70.70 2 A SER 9 173.22 -176.51 2 A CYS 20 -40.90 166.16 2 B VAL 2 -79.96 -88.95 2 B ASN 3 -94.19 -97.16 2 B GLN 4 -160.79 -27.78 2 B LEU 6 -160.11 119.47 2 B SER 9 -39.78 -29.53 2 B CYS 19 -72.32 -70.43 2 B THR 27 -40.59 -87.12 2 B PRO 29 -58.60 -158.41 3 A CYS 6 -57.58 -77.58 3 A THR 8 -84.95 -71.90 3 A SER 9 -117.60 -106.94 3 A ILE 10 -79.89 -128.28 3 A CYS 11 179.30 105.81 3 B CYS 7 179.82 155.79 3 B CYS 19 -64.61 -76.43 3 B THR 27 -153.75 -55.71 3 B LYS 28 59.46 89.07 4 A VAL 3 -90.68 43.34 4 A CYS 6 -72.22 -80.52 4 A CYS 7 -75.95 28.34 4 A SER 9 -160.06 -80.68 4 B ASN 3 -145.25 -81.92 4 B GLN 4 -162.01 -9.32 4 B HIS 5 -50.67 102.52 4 B SER 9 -47.69 -10.20 4 B LEU 15 -36.80 -36.66 4 B CYS 19 -51.54 -83.00 4 B ARG 22 179.97 -36.41 4 B PHE 24 -120.46 -169.29 4 B PHE 25 -142.26 -99.25 4 B TYR 26 -164.61 -163.47 5 A CYS 6 -72.95 -72.13 5 A SER 9 -156.74 -85.30 5 A CYS 11 -157.90 -159.17 5 A CYS 20 -45.35 158.54 5 B VAL 2 -160.42 -156.50 5 B DSN 8 39.12 -129.76 5 B SER 9 -54.59 -1.14 5 B LEU 15 -37.18 -36.54 5 B PHE 25 -79.96 -93.62 5 B TYR 26 -164.18 -79.09 5 B THR 27 -154.03 -50.30 5 B LYS 28 57.12 97.74 6 A GLU 4 -90.24 -72.35 6 A SER 9 -143.23 -130.62 6 A CYS 11 -123.31 -142.70 6 A CYS 20 -20.59 118.28 6 B ASN 3 172.71 -76.32 6 B GLN 4 -160.82 -10.94 6 B SER 9 -55.57 8.38 6 B LEU 15 -36.63 -31.95 6 B CYS 19 -62.23 -89.13 6 B GLU 21 -123.95 -86.20 6 B PHE 25 -84.89 -85.94 6 B TYR 26 -163.99 -72.88 6 B THR 27 -153.47 -74.46 6 B LYS 28 -150.62 78.80 7 A SER 9 -154.19 -94.27 7 B VAL 2 -128.87 -88.12 7 B SER 9 -55.30 7.42 7 B ALA 14 -49.56 -70.71 7 B LEU 15 -37.23 -32.30 7 B GLU 21 168.67 -32.63 7 B PHE 25 -85.22 -91.81 7 B TYR 26 -164.38 -66.51 7 B THR 27 -146.12 -84.15 7 B LYS 28 -173.11 57.09 8 A GLU 4 -83.38 -85.21 8 A CYS 6 -73.17 -79.66 8 A SER 9 -162.89 -130.46 8 B ASN 3 -145.51 52.68 8 B DSN 8 48.81 -151.92 8 B SER 9 -52.28 4.13 8 B PHE 25 -151.06 -94.12 8 B TYR 26 -164.57 -142.50 8 B LYS 28 52.75 99.98 9 A GLU 4 -49.39 -77.16 9 A GLN 5 -39.69 -34.86 9 A SER 9 81.88 -164.60 9 A CYS 11 -126.42 -152.03 9 A CYS 20 -35.17 114.46 9 B VAL 2 -159.95 -48.49 9 B ASN 3 -152.89 -97.15 9 B GLN 4 -160.84 23.44 9 B SER 9 -52.44 -2.70 9 B CYS 19 -82.34 -87.65 9 B GLU 21 -99.90 -67.87 9 B ARG 22 -163.98 68.74 9 B THR 27 -159.79 -81.95 9 B LYS 28 51.02 71.07 9 B PRO 29 -68.66 64.25 10 A VAL 3 -59.33 92.94 10 A CYS 6 -48.17 -93.43 10 A THR 8 -82.07 -94.39 10 A SER 9 -101.30 -124.74 10 B ASN 3 174.88 60.68 10 B GLN 4 -159.69 -143.87 10 B SER 9 -58.16 6.85 10 B LEU 15 -36.59 -36.26 10 B CYS 19 -63.01 -75.87 10 B GLU 21 166.80 60.88 10 B PHE 25 -160.63 112.31 11 A ILE 2 -58.99 -94.09 11 A CYS 7 -66.99 11.12 11 A SER 9 -152.13 -94.68 11 A CYS 20 -36.10 149.03 11 B ASN 3 176.02 40.53 11 B GLN 4 -145.42 -132.20 11 B HIS 5 -49.40 102.68 11 B SER 9 -56.47 5.36 11 B ASP 10 -91.80 -61.11 11 B GLU 21 164.88 -31.50 11 B PHE 24 -110.88 -167.35 11 B THR 27 -146.21 -69.27 11 B LYS 28 26.79 -84.68 11 B PRO 29 -58.10 -165.34 12 A GLU 4 -86.16 -90.60 12 A CYS 6 -61.84 -82.80 12 A SER 9 -165.32 -135.79 12 A CYS 20 -35.06 112.47 12 B ASN 3 178.08 -78.00 12 B GLN 4 -162.05 19.23 12 B SER 9 -55.00 1.77 12 B ASP 10 -91.70 -60.42 12 B LEU 15 -37.38 -36.27 12 B PHE 25 -160.90 107.13 12 B TYR 26 -77.31 -145.75 12 B THR 27 -79.55 -101.31 12 B LYS 28 43.63 88.31 12 B PRO 29 -68.64 63.82 13 A VAL 3 -39.36 88.00 13 A THR 8 -135.94 -38.86 13 A SER 9 -145.32 -159.78 13 A LEU 13 -39.71 -34.88 13 B ASN 3 -68.04 64.10 13 B CYS 7 142.22 149.72 13 B SER 9 -39.64 -32.17 13 B CYS 19 -65.51 -77.13 13 B THR 27 161.49 133.15 13 B LYS 28 -47.18 102.59 13 B PRO 29 -62.59 -158.80 14 A ILE 2 -90.24 -74.49 14 A VAL 3 -90.51 38.34 14 A SER 9 -139.78 -86.30 14 B ASN 3 -64.48 97.71 14 B SER 9 -56.08 2.71 14 B LEU 15 -36.34 -34.81 14 B GLU 21 178.81 -40.95 14 B PHE 25 -143.18 -90.43 14 B TYR 26 -164.59 -82.24 14 B THR 27 -145.81 -50.76 14 B PRO 29 -48.66 92.27 15 A SER 9 -176.40 -66.88 15 B CYS 7 171.94 175.45 15 B CYS 19 -75.98 -77.48 15 B THR 27 -44.77 -86.52 15 B LYS 28 -138.74 -68.52 16 A GLU 4 -90.41 -104.74 16 A CYS 6 -90.41 -66.92 16 A SER 9 178.32 -160.49 16 B VAL 2 -115.49 -154.06 16 B ASN 3 -50.43 -81.86 16 B GLN 4 -163.15 -31.93 16 B HIS 5 -42.79 109.56 16 B CYS 7 179.16 144.27 16 B CYS 19 -85.21 -70.63 16 B TYR 26 -93.72 -75.35 16 B THR 27 148.85 131.70 16 B PRO 29 -58.28 106.14 17 A ILE 2 -89.98 -74.05 17 A THR 8 -108.74 -104.76 17 A SER 9 -99.73 -83.51 17 B GLN 4 -132.89 -151.00 17 B LEU 6 -151.04 -159.99 17 B CYS 7 165.50 149.51 17 B DSN 8 40.20 -152.63 17 B SER 9 -37.81 -36.73 17 B THR 27 -86.71 -98.17 18 A GLU 4 -90.38 -60.13 18 A CYS 7 -90.79 38.83 18 A THR 8 -143.47 -47.82 18 A SER 9 -147.11 -79.43 18 B ASN 3 -66.97 87.83 18 B CYS 7 175.16 152.98 18 B SER 9 -35.21 -34.89 18 B CYS 19 -60.77 -74.12 18 B THR 27 173.54 -67.52 18 B LYS 28 56.69 95.59 18 B PRO 29 -68.09 89.39 19 A SER 9 -151.14 -159.77 19 B CYS 7 -173.48 -175.72 19 B CYS 19 -68.81 -76.72 19 B THR 27 -145.61 -118.88 19 B LYS 28 176.17 64.09 20 A VAL 3 -90.29 45.13 20 A THR 8 -113.38 -70.16 20 A SER 9 -103.40 -160.53 20 A CYS 11 -113.65 -150.05 20 A CYS 20 -53.49 177.73 20 B ASN 3 30.47 -126.50 20 B GLN 4 -161.02 15.73 20 B CYS 19 -67.17 -80.37 20 B THR 27 -49.80 -91.89 20 B LYS 28 53.92 171.54 20 B PRO 29 -57.80 108.27 NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures 1 N N 2 N N A VAL 3 A VAL 3 HELX_P A SER 9 A SER 9 1 1 7 A SER 12 A SER 12 HELX_P A CYS 20 A CYS 20 1 2 9 B CYS 7 B CYS 7 HELX_P B GLY 20 B GLY 20 1 3 14 disulf 2.030 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.026 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.028 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 covale 1.329 both B CYS 7 B C CYS 7 1_555 B DSN 8 B N DSN 8 1_555 covale 1.338 both B DSN 8 B C DSN 8 1_555 B SER 9 B N SER 9 1_555 HORMONE/GROWTH FACTOR HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX Q5EEX2_HUMAN UNP 1 90 Q5EEX2 GIVEQCCTSICSLYQLENYCN Q5EEX2_HUMAN UNP 2 25 Q5EEX2 FVNQHLCGSHLVEALYLVCGERGFFYTPKT 90 110 2HH4 1 21 Q5EEX2 A 1 1 21 25 54 2HH4 1 30 Q5EEX2 B 2 1 30 2 GLY engineered mutation DSN 8 2HH4 B Q5EEX2 UNP 32 8 2 HIS engineered mutation ASP 10 2HH4 B Q5EEX2 UNP 34 10 2 PRO engineered mutation LYS 28 2HH4 B Q5EEX2 UNP 52 28 2 LYS engineered mutation PRO 29 2HH4 B Q5EEX2 UNP 53 29 1 P 1